Fifth Third Bancorp (FITB) 19.75 $FITB Fifth Third

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 8:37 PM

Fifth Third Bancorp (FITB) 19.75 $FITB

Fifth Third Bancorp (FITB) Crosses Pivot Point Resistance at $19.62
Comtex SmarTrend(R) - Wed Apr 22, 9:34AM CDT
Shares of Fifth Third Bancorp (NASDAQ:FITB) opened today above their pivot of $19.39 and have already reached the first level of resistance at $19.62. Analysts will be watching for a cross of the next upside pivot targets of $19.84 and $20.29.
FITB: 19.75 (+0.34)

Company News for April 22, 2015 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 9:10AM CDT
Companies in the News are: PCAR,VZ,LMT,FITB
FITB: 19.75 (+0.34), LMT: 197.63 (+1.34), PCAR: 67.41 (+0.69), VZ: 49.57 (+0.40)

Low-rate "torture" for the regional lenders
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 8:37PM CDT

UYG: 147.26 (+2.37), KBE: 34.14 (+0.22), RF: 9.73 (+0.15), QABA: 36.98 (+0.02), KRE: 41.56 (+0.29), FXO: 23.73 (+0.09), FNCL: 28.90 (+0.17), FAS: 124.77 (+2.96), PNC: 91.41 (+0.21), FAZ: 12.06 (-0.30), XLF: 24.28 (+0.17), RYF: 44.59 (+0.27), FINZ: 22.15 (+0.54), FITB: 19.75 (+0.34), SEF: 17.42 (-0.11), VFH: 49.57 (+0.31), KRS: 26.06 (unch), KBWB: 37.77 (+0.37), FINU: 84.30 (+0.28), KRU: 95.61 (+1.13), BAC: 15.74 (+0.24), WFC: 54.67 (+0.39), IYG: 91.22 (+1.10), IYF: 89.68 (+0.76), USB: 42.83 (+0.33), KBWR: 40.78 (-0.01), RWW: 48.98 (+0.31), IAT: 34.93 (+0.22)

Fifth Third Bancorp (FITB) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Tue Apr 21, 6:22PM CDT
The following Fifth Third Bancorp (FITB) conference call took place on April 21, 2015, 09:00 AM ET. This is a transcript of that earnings call:
FITB: 19.75 (+0.34)

Fifth Third Bancorp Set to Possibly Pullback After Yesterday's Rally of 2.21%
Comtex SmarTrend(R) - Tue Apr 21, 4:23PM CDT
Fifth Third Bancorp (NASDAQ:FITB) traded in a range yesterday that spanned from a low of $19.15 to a high of $19.60. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $19.36 on volume of 14.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FITB: 19.75 (+0.34)

Fifth Third Bancorp Rises 2.21% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Apr 21, 4:22PM CDT
Fifth Third Bancorp (NASDAQ:FITB) traded in a range yesterday that spanned from a low of $19.15 to a high of $19.60. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $19.36 on volume of 14.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
FITB: 19.75 (+0.34)

Fifth Third Bancorp (FITB) Kevin T. Kabat on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Apr 21, 2:03PM CDT

FITB: 19.75 (+0.34)

Fifth Third Bancorp (FITB) Stock Gains Today Following Earnings Beat
at The Street - Tue Apr 21, 1:02PM CDT
Fifth Third Bancorp (FITB) shares are rising after the company beat analysts' earnings and revenue expectations for the period.
FITB: 19.75 (+0.34)

Fifth Third's (FITB) Q1 Earnings Beat on Better Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 11:57AM CDT
Fifth Third Bancorp's (FITB) first-quarter 2015 earnings per share came in at 44 cents, beating the Zacks Consensus Estimate by 18.9%. Moreover, the reported figure compared favorably with the prior-year quarter earnings.
FITB: 19.75 (+0.34), C: 53.10 (+0.62), BAC: 15.74 (+0.24), WFC: 54.67 (+0.39)

Reassessing Fifth Third Bancorp
Christopher F. Davis - at Seeking Alpha - Tue Apr 21, 10:57AM CDT

FITB: 19.75 (+0.34)

US stocks open broadly higher as company earnings impress
AP - Tue Apr 21, 8:40AM CDT
NEW YORK (AP) — U.S. stocks are opening slightly higher as more companies turn in healthy earnings reports.
FITB: 19.75 (+0.34)

Fifth Third Bancorp (FITB) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Apr 21, 7:55AM CDT

FITB: 19.75 (+0.34)

Slimming margins at Fifth Third
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 6:52AM CDT

FITB: 19.75 (+0.34)

Fifth Third meets 1Q profit forecasts
AP - Tue Apr 21, 6:00AM CDT
CINCINNATI (AP) — Fifth Third Bancorp (FITB) on Tuesday reported first-quarter profit of $382 million.
FITB: 19.75 (+0.34)

Fifth Third Bancorp EPS in-line, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 5:34AM CDT

FITB: 19.75 (+0.34)

Fifth Third Announces First Quarter 2015 Net Income to Common Shareholders of $367 Million, or $0.44 Per Diluted Share
Business Wire - Tue Apr 21, 5:30AM CDT
--1Q15 return on average assets (ROA) of 1.12%; return on average common equity of 10.3%; return on average tangible common equity** of 12.3%
FITB: 19.75 (+0.34), VNTV: 39.13 (-0.17)

Notable earnings before Tuesday’s open
Seeking Alpha - at Seeking Alpha - Mon Apr 20, 4:30PM CDT

CLS: 12.01 (+0.07), HOG: 56.23 (+0.51), LMT: 197.63 (+1.34), RF: 9.73 (+0.15), PCAR: 67.41 (+0.69), GPC: 93.02 (+0.57), UTX: 116.96 (+0.01), KMB: 111.85 (-1.30), KSU: 106.24 (+1.07), PNR: 60.51 (-1.26), EAT: 56.95 (+0.11), TTS: 14.52 (-0.33), SAP: 74.43 (+0.29), JAKK: 6.78 (unch), ACI: 1.02 (+0.02), SNV: 28.21 (+0.06), DD: 71.44 (+0.75), TCB: 15.41 (+0.16), TRV: 102.02 (+0.14), BHI: 67.07 (-0.28), ATI: 34.29 (-0.36), FITB: 19.75 (+0.34), CS: 26.60 (-0.02), MAN: 83.66 (-0.35), EDU: 26.09 (+0.76), SBNY: 135.17 (-1.18), SAH: 24.44 (+0.22), LECO: 66.32 (-0.15), ITW: 94.44 (+0.02), UA: 82.27 (-1.25), OMC: 77.86 (+1.22), NTRS: 73.84 (+1.95), WIT: 11.69 (-0.39), ABG: 86.97 (-0.16), GCI: 35.17 (-0.83), ARMH: 54.07 (+0.47), LPT: 35.60 (-0.39), DOV: 71.89 (-0.04), CP: 195.00 (+6.08), MTG: 10.57 (+0.10), MLNX: 49.54 (+1.24), VZ: 49.57 (+0.40), AMTD: 35.64 (+0.22), NVR: 1,338.85 (-16.48)

What to Expect When Fifth Third Bancorp (FITB) Reports First-Quarter Earnings Tuesday
at The Street - Mon Apr 20, 2:33PM CDT
Shares of Fifth Third Bancorp (FITB) were up in afternoon trading Monday ahead of the financial company's first-quarter earnings report scheduled for before the market open Tuesday.
FITB: 19.75 (+0.34)

Will Rising Expenses Hurt BNY Mellon's (BK) Q1 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 20, 2:30PM CDT
Will BNY Mellon be able to overcome industry challenges? Or will it disappoint again? Let's see how things have shaped up for this announcement.
FITB: 19.75 (+0.34), STT: 77.93 (+1.26), BKU: 33.64 (+0.12), BK: 42.43 (+1.39)

What Morgan Stanley Analysts See in Fifth Third Bank
at The Street - Mon Apr 20, 11:04AM CDT
One macroeconomic factor buoying Fifth Third is a strong U.S. dollar, which generally favors financial institutions.
FITB: 19.75 (+0.34), MS: 37.20 (+0.45)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

LG's ASIL D Certification: A Game Changer in Autos

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

D-Wave's Legal Trouble: Securities Fraud Suit Looms

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...